Adrenal Insufficiency in Septic Shock

Angus, 2001, Epidemiology of severe sepsis in the United States: analysis of incidence, outcome, and associated costs of care, Crit Care Med, 29, 1303, 10.1097/00003246-200107000-00002 Schroeder, 2001, The hypothalamic-pituitary-adrenal axis of patients with severe sepsis: altered response to corticotropin-releasing hormone, Crit Care Med, 29, 310, 10.1097/00003246-200102000-00017 Russell, 2008, Vasopressin versus norepinephrine infusion in patients with septic shock, N Engl J Med, 358, 877, 10.1056/NEJMoa067373 Parrillo, 2008, Septic shock-vasopressin, norepinephrine, and urgency, N Engl J Med, 358, 954, 10.1056/NEJMe0800245 Bernard, 1997, The effects of ibuprofen on the physiology and survival of patients with sepsis. The Ibuprofen in Sepsis Study Group, N Engl J Med, 336, 912, 10.1056/NEJM199703273361303 Maxime, 2007, Metabolism modulators in sepsis: the abnormal pituitary response, Crit Care Med, 35, S596, 10.1097/01.CCM.0000279097.67263.52 Betancur, 1995, Cytokine regulation of corticosteroid receptors in the rat hippocampus: effects of interleukin-1, interleukin-6, tumor necrosis factor and lipopolysaccharide, Neuroendocrinology, 62, 47, 10.1159/000126987 Imura, 1994, Endocrine-paracrine interaction in communication between the immune and endocrine systems. Activation of the hypothalamic-pituitary-adrenal axis in inflammation, Eur J Endocrinol, 130, 32, 10.1530/eje.0.1300032 Sternberg, 1995, Neuroendocrine factors in susceptibility to inflammatory disease: focus on the hypothalamic-pituitary-adrenal axis, Horm Res, 43, 159, 10.1159/000184268 Elenkov, 2006, Stress system—organization, physiology and immunoregulation, Neuroimmunomodulation, 13, 257, 10.1159/000104853 Pinsky, 1993, Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality, Chest, 103, 565, 10.1378/chest.103.2.565 Thijs, 1995, Time course of cytokine levels in sepsis, Intensive Care Med, 21, S258, 10.1007/BF01740764 Loisa, 2002, Adrenocortical function and multiple organ failure in severe sepsis, Acta Anaesthesiol Scand, 46, 145, 10.1034/j.1399-6576.2002.460204.x Abraham, 2007, Mechanisms of sepsis-induced organ dysfunction, Crit Care Med, 35, 2408, 10.1097/01.CCM.0000282072.56245.91 Marik, 2002, Adrenal insufficiency in the critically ill: a new look at an old problem, Chest, 122, 1784, 10.1378/chest.122.5.1784 Annane, 2002, Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock, JAMA, 288, 862, 10.1001/jama.288.7.862 Bone, 1992, Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine, Chest, 101, 1644, 10.1378/chest.101.6.1644 Guillon, 1990, Involvement of distinct G-proteins in the action of vasopressin on rat glomerulosa cells, Endocrinology, 126, 1699, 10.1210/endo-126-3-1699 Brown-Sequard, 1856, Recherches expérimentales sur la physiologie et la pathologies des capsules surrenales, C R Hebd Séances Acad Sci (Paris), 43, 422 Collip, 1933, The adrenotropic hormone of the anterior pituitary lobe, Lancet, 2, 347, 10.1016/S0140-6736(00)44463-6 Gallo-Payet, 1998, Regulation of adrenocortical function by vasopressin, Horm Metab Res, 30, 360, 10.1055/s-2007-978899 Oelkers, 1989, Hyponatremia and inappropriate secretion of vasopressin (antidiuretic hormone) in patients with hypopituitarism, N Engl J Med, 321, 492, 10.1056/NEJM198908243210802 Papanek, 1994, Chronic physiological increases in cortisol inhibit the vasopressin response to hypertonicity in conscious dogs, Am J Physiol, 267, R1342 Holmes, 2001, Physiology of vasopressin relevant to management of septic shock, Chest, 120, 989, 10.1378/chest.120.3.989 Mutlu, 2004, Role of vasopressin in the management of septic shock, Intensive Care Med, 30, 1276, 10.1007/s00134-004-2283-8 Antoni, 1993, Vasopressinergic control of pituitary adrenocorticotropin secretion comes of age, Front Neuroendocrinol, 14, 76, 10.1006/frne.1993.1004 Saavedra, 2007, Brain and peripheral angiotensin II play a major role in stress, Stress, 10, 185, 10.1080/10253890701350735 Aguilera, 1995, Direct regulation of hypothalamic corticotropin-releasing-hormone neurons by angiotensin II, Neuroendocrinology, 61, 437, 10.1159/000126866 Aguilera, 1995, Increased expression of type 1 angiotensin II receptors in the hypothalamic paraventricular nucleus following stress and glucocorticoid administration, J Neuroendocrinol, 7, 775, 10.1111/j.1365-2826.1995.tb00714.x Castren, 1989, Angiotensin II receptors in paraventricular nucleus, subfornical organ, and pituitary gland of hypophysectomized, adrenalectomized, and vasopressin-deficient rats, Proc Natl Acad Sci U S A, 86, 725, 10.1073/pnas.86.2.725 Tatemoto, 1998, Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor, Biochem Biophys Res Commun, 251, 471, 10.1006/bbrc.1998.9489 Renner, 1996, Autocrine and paracrine roles of polypeptide growth factors, cytokines and vasogenic substances in normal and tumorous pituitary function and growth: a review, Eur J Endocrinol, 135, 515, 10.1530/eje.0.1350515 Schwartz, 1992, Intercellular communication within the anterior pituitary influencing the secretion of hypophysial hormones, Endocr Rev, 13, 453 Kleinz, 2005, Emerging roles of apelin in biology and medicine, Pharmacol Ther, 107, 198, 10.1016/j.pharmthera.2005.04.001 Reaux, 2001, Physiological role of a novel neuropeptide, apelin, and its receptor in the rat brain, J Neurochem, 77, 1085, 10.1046/j.1471-4159.2001.00320.x Reaux, 2002, Distribution of apelin-synthesizing neurons in the adult rat brain, Neuroscience, 113, 653, 10.1016/S0306-4522(02)00192-6 Reaux-Le Goazigo, 2007, Cellular localization of apelin and its receptor in the anterior pituitary: evidence for a direct stimulatory action of apelin on ACTH release, Am J Physiol Endocrinol Metab, 292, E7, 10.1152/ajpendo.00521.2005 Gallo-Payet N, Roussy JF, Chagnon F, Roberge C, Lesur O. Hypothalamic/pituitary/adrenal axis and multiorgan defaillance system in critical illness; a special focus on arginine-vasopressin and apelin. J Organ Dysfunc 4, in press. O'Dowd, 1993, A human gene that shows identity with the gene encoding the angiotensin receptor is located on chromosome 11, Gene, 136, 355, 10.1016/0378-1119(93)90495-O Cope, 1958, The production rate of cortisol in man, Br Med J, 1, 1020, 10.1136/bmj.1.5078.1020 Kraft, 1995, Chronobiology and chronotherapy in medicine, Dis Mon, 41, 501, 10.1016/S0011-5029(95)90036-5 Daughaday, 1956, Binding of corticosteroids by plasma proteins. I. Dialysis equilibrium and renal clearance studies, J Clin Invest, 355, 1428, 10.1172/JCI103400 Forest, 1986, vol. 149 Siiteri, 1982, The serum transport of steroid hormones, Recent Prog Horm Res, 38, 457 Santini, 2001, The human pharmacology of monocyte cyclooxygenase 2 inhibition by cortisol and synthetic glucocorticoids, Clin Pharmacol Ther, 70, 475, 10.1067/mcp.2001.119213 Tajima, 1984, Mechanism of action of an anti-inflammatory steroid on changes in vascular permeability (II). Evaluation of its action as a phospholipase A2 inhibitor, Josai Shika Daigaku Kiyo, 13, 60 Anderson, 1991, Binding activity of glucocorticoid receptors after heat shock, Exp cell Res, 197, 100, 10.1016/0014-4827(91)90485-D Hart, 2000, Effects of inhaled corticosteroid therapy on expression and DNA-binding activity of nuclear factor κB, Am J Respir Crit Care Med, 161, 224, 10.1164/ajrccm.161.1.9809019 Scheinman, 1995, Role of transcriptional activation of IkBα in mediation of immunosuppression by glucocorticoids, Science, 270, 283, 10.1126/science.270.5234.283 Yende S, Angus DC, Bucala R. MIF and MODS. J Organ Dysf 4, in press. Calandra, 1995, MIF as a glucocorticoid-induced modulator of cytokine production, Nature, 377, 68, 10.1038/377068a0 Melby, 1958, Comparative studies on adrenal cortical function and cortisol metabolism in healthy adults and in patients with shock due to infection, J Clin Invest, 37, 1791, 10.1172/JCI103772 Koo, 2001, Adrenal insufficiency during the late stage of polymicrobial sepsis, Crit Care Med, 29, 618, 10.1097/00003246-200103000-00026 McCann, 2006, Chronology of advances in neuroendocrine immunomodulation, Ann N Y Acad Sci, 1088, 1, 10.1196/annals.1366.010 Itoi, 1999, Differential regulation of corticotropin-releasing hormone and vasopressin gene transcription in the hypothalamus by norepinephrine, J Neurosci, 19, 5464, 10.1523/JNEUROSCI.19-13-05464.1999 Dünser, 2004, Endocrinologic response to vasopressin infusion in advanced vasodilatory shock, Crit Care Med, 32, 1266, 10.1097/01.CCM.0000127264.54807.B7 Lauzier, 2006, Vasopressin or norepinephrine in early hyperdynamic septic shock: a randomized clinical trial, Intensive Care Med, 32, 1782, 10.1007/s00134-006-0378-0 Sharshar, 2003, Circulating vasopressin levels in septic shock, Crit Care Med, 31, 1752, 10.1097/01.CCM.0000063046.82359.4A Hamrahian, 2004, Measurements of serum free cortisol in critically ill patients, N Engl J Med, 350, 1629, 10.1056/NEJMoa020266 Cooper, 2001, Modulation of 11β-hydroxysteroid deshydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation, J Bone Miner Res, 16, 1037, 10.1359/jbmr.2001.16.6.1037 Venkatesh, 2007, Evidence of altered cortisol metabolism in critically ill patients: a prospective study, Intensive Care Med, 33, 1746, 10.1007/s00134-007-0727-7 Marik, 2006, The diagnosis of adrenal insufficiency in the critically ill patient: Does it really matter?, Crit Care, 10, 176, 10.1186/cc5105 Annane, 2003, Time for consensus definition of corticosteroid insufficiency in critically ill patients, Crit Care Med, 31, 1868, 10.1097/01.CCM.0000063445.91548.20 Annane, 2000, A 3-level prognostic classification in septic shock based on cortisol levels and cortisol response to corticotrophin, JAMA, 283, 1038, 10.1001/jama.283.8.1038 Prigent, 2004, Science review: mechanisms of impaired adrenal function in sepsis and molecular actions of glucocorticoids, Crit Care, 8, 243, 10.1186/cc2878 Waterhouse, 1911, Case of suprarenal apoplexy, Lancet, 1, 577, 10.1016/S0140-6736(01)60988-7 2001, Case records of the Massachusetts Heneral Hospital (case 15–2001), N Engl J Med, 344, 1536 Cooper, 2003, Corticosteroid insufficiency in acutely ill patients, N Engl J Med, 348, 727, 10.1056/NEJMra020529 Sharshar, 2003, Apoptosis of neurons in cardiovascular autonomic centres triggered by inductible nitric oxide synthase after death from septic shock, Lancet, 362, 1799, 10.1016/S0140-6736(03)14899-4 Wagner, 1984, Inhibition of adrenal steroidogenesis by the anesthetic etomidate, N Engl J Med, 310, 1415, 10.1056/NEJM198405313102202 Mohammad, 2006, The incidence of relative adrenal insufficiency in patients with septic shock after the administration of etomidate, Crit Care, 10, R105, 10.1186/cc4979 Albert, 2001, Possible association between high-dose fluconazole and adrenal insufficiency in critical ill patients, Crit Care Med, 29, 668, 10.1097/00003246-200103000-00039 Vinclair, 2008, Duration of adrenal inhibition following a single dose of etomidate in critically ill patients, Intensive Care Med, 34, 714, 10.1007/s00134-007-0970-y Sprung, 2008, Hydrocortisone therapy for patients with septic shock, N Engl J Med., 358, 111, 10.1056/NEJMoa071366 Pascualy, 2000, Hypothalamic pituitary adrenocortical and sympathetic nervous system responses to the cold pressor test in Alzheimer's disease, Biol Psychiatry, 48, 247, 10.1016/S0006-3223(00)00879-9 Cho, 2000, Dissociation between plasma adrenocorticotropin and serum cortisol level during the early post operative period after gastrectomy, Horm Res, 53, 246, 10.1159/000023574 Droste, 2003, Effects of long term voluntary exercise on the mouse hypothalamic-pituitary adrenal axis, Endocrinology, 144, 3012, 10.1210/en.2003-0097 Droste, 2007, Voluntary exercise impacts on the rat hypothalamic-pituitary adrenal axis mainly at the adrenal level, Neuroendocrinology, 86, 26, 10.1159/000104770 Bornstein, 2008, Dissociation of ACTH and glucocorticoids, Trends Endocrinol Metab, 19, 175, 10.1016/j.tem.2008.01.009 Dorin, 2003, Diagnosis of adrenal insufficiency, Ann Intern Med, 139, 194, 10.7326/0003-4819-139-3-200308050-00017 Marik, 2008, Recommendations for the diagnosis and management of corticosteroid insufficiency in critical ill adult patients: consensus statements from an international task force by the American College of Critical Care Medicine, Crit Care Med, 36, 1937, 10.1097/CCM.0b013e31817603ba Arafah, 2007, Measurement of salivary cortisol concentration in the assessment adrenal function in critical ill subjects: a surrogate marker of the circulating free cortisol, J Clin Endocrinol Metab, 92, 2965, 10.1210/jc.2007-0181 Sederberg-Olsen, 1975, Urinary excretion of free cortisol in impaired renal function, Acta Endocrinol, 78, 86, 10.1530/acta.0.0780086 Annane, 2006, Diagnosis of adrenal insufficiency in severe sepsis and septic shock, Am J Respir Crit Care Med, 174, 1319, 10.1164/rccm.200509-1369OC Slotman GJ, Fisher CJ, Bone RC, et al. Detrimental effects of high dose methylprednisolone sodium succinate on serum concentrations of hepatic and renal function indicators in severe sepsis and septic shock. The Methylprednisolone Severe Sepsis Study Group. Crit Care Med;21(2):191–5. Annane, 2004, Corticosteroids for severe sepsis and septic shock: a systematic review and meta-analysis, Br Med J, 329, 480, 10.1136/bmj.38181.482222.55 Dellinger, 2008, Surviving Sepsis Campaign: international guidelines for management of sever sepsis and septic shock: 2008, Crit Care Med, 36, 296, 10.1097/01.CCM.0000298158.12101.41 De Jonghe, 2002, Paresis acquired in the intensive care unit: a prospective multicenter study, JAMA, 288, 2859, 10.1001/jama.288.22.2859 Herridge, 2003, One-year outcomes in survivors of the acute respiratory distress syndrome, N Engl J Med, 348, 683, 10.1056/NEJMoa022450 Van den Berghe, 2005, Insulin therapy protects the central and peripheral nervous system of intensive care patients, Neurology, 64, 1348, 10.1212/01.WNL.0000158442.08857.FC Hermans, 2007, Impact of intensive insulin therapy on neuromuscular complications and ventilator dependency in the medical intensive care unit, Am J Respir Crit Care Med, 175, 480, 10.1164/rccm.200605-665OC Bollaert, 1998, Reversal of late septic shock with supraphysiologic doses of hydrocortisone, Crit Care Med, 26, 645, 10.1097/00003246-199804000-00010 Briegel, 1999, Stress doses of hydrocortisone reverse hyperdynamic septic shock: a prospective, randomized, double-blind, single center study, Crit Care Med, 27, 723, 10.1097/00003246-199904000-00025 Chawla, 1999, Hydrocortisone reverses refractory septic shock, Crit Care Med, 27, A33, 10.1097/00003246-199901001-00022 Yildiz, 2002, Physiological-dose steroid therapy in sepsis, Crit Care, 6, 251, 10.1186/cc1498 Keh, 2003, Immunologic and hemodynamic effects of “low-dose” hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study, Am J Respir Crit Care Med, 167, 512, 10.1164/rccm.200205-446OC Confalonieri, 2005, Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study, Am J Respir Crit Care Med, 171, 242, 10.1164/rccm.200406-808OC Oppert, 2005, Low-dose hydrocortisone improves shock reversal and reduces cytokine levels in early hyperdynamic septic shock, Crit Care Med, 33, 2457, 10.1097/01.CCM.0000186370.78639.23 Tandan, 2005, Low dose steroids and adrenocortical insufficiency in septic shock: a double-blind randomised controlled trial from India, Am J Respir Crit Care Med, A24 Rinaldi, 2006, Low-dose hydrocortisone during severe sepsis: effects on microalbuminuria, Crit Care Med, 34, 2334, 10.1097/01.CCM.0000233872.04706.BB Cicarelli, 2007, Early dexamethasone treatment for septic shock patients: a prospective randomized clinical trial, Sao Paulo Med J, 125, 237, 10.1590/S1516-31802007000400009 Mikami, 2007, Efficacy of corticosteroids in the treatment of community-acquired pneumonia requiring hospitalization, Lung, 185, 249, 10.1007/s00408-007-9020-3 Huh, 2007, Effect of low doses of hydrocortisone in patient with septic shock and relative adrenal insufficiency: 3 days versus 7 days treatment, Crit Care Med, 34, A101, 10.1097/00003246-200612002-00350